Walgreens' Strategic Pivot

Justin Sullivan Investment Thesis The challenges for retail pharmacy giant Walgreens Boots Alliance, Inc. (NASDAQ:WBA) are profound, with lower demand from consumers seeking vaccinations and testing for COVID-19 on one hand and tight reins on prescription drug payouts hobbling its operations. But most crucially, the company's assertive push into other healthcare businesses faces a few sticking points that show catching up might take some time. Over the past three years, Walgreens has lost nearly 60% in  ...